Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4868 total record number 240 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 3 out of 487
4868 citations found

Specific CD4+ T cell phenotypes associate with bacterial control in people who ‘resist’ infection with Mycobacterium tuberculosis

Sun, M;Phan, JM;Kieswetter, NS;Huang, H;Yu, KKQ;Smith, MT;Liu, YE;Wang, C;Gupta, S;Obermoser, G;Maecker, HT;Krishnan, A;Suresh, S;Gupta, N;Rieck, M;Acs, P;Ghanizada, M;Chiou, SH;Khatri, P;Boom, WH;Hawn, TR;Stein, CM;Mayanja-Kizza, H;Davis, MM;Seshadri, C;

Product: Enterotoxin Type B from Staphylococcus aureus

  • for CFP10. Mtb whole-cell lysate from H37Rv was also used to stimulate T cells (BEI Resources). Dimethyl sulfoxide (DMSO) (Sigma-Aldrich) was used as a negative control. Staphylococcus enterotoxin B (List Biological Laboratories) was used as a positive control for the low-exposure cohort. ICS ICS was performed on samples from the low-exposure cohort as we have previously described5. The same ICS ... for CFP10. Mtb whole-cell lysate from H37Rv was also used to stimulate T cells (BEI Resources). Dimethyl sulfoxide (DMSO) (Sigma-Aldrich) was used as a negative control. Staphylococcus enterotoxin B (List Biological Laboratories) was used as a positive control for the low-exposure cohort. ICS ICS was performed on samples from the low-exposure cohort as we have previously described5. The same ICS

BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells

Thakore, PI;Schnell, A;Huang, L;Zhao, M;Hou, Y;Christian, E;Zaghouani, S;Wang, C;Singh, V;Singaraju, A;Krishnan, RK;Kozoriz, D;Ma, S;Sankar, V;Notarbartolo, S;Buenrostro, JD;Sallusto, F;Patsopoulos, NA;Rozenblatt-Rosen, O;Kuchroo, VK;Regev, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • H37Ra extract (5?mg?ml-1; Becton Dickinson) in complete Freund’s adjuvent (200??l per mouse; Becton Dickinson). Pertussis toxin (100?ng per mouse; List Biological Laboratories) was injected intravenously on days 0 and 2 after immunization. The course of EAE disease was monitored daily, and each mouse was assigned a clinical score according to the following criteria: 0, no sym

Vaccinia virus F1Lblocks the ribotoxic stress response to subvert ZAK?-dependent NLRP1 inflammasome activation

Szymanska, I;Bauernfried, S;Komar, T;Hornung, V;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • 20187, MedChem Express), 20 µM Z-VAD-FMK (Peptanova), 10 µM cytarabine (Ara C, Sigma Aldrich), 1 µM MLN4924 (MLN), 1 µg/mL anthrax lethal factor, and 1 µg/mL protective antigen (both List Biological Labs). For poly(I:C) transfection, a transfection mix of poly(I:C) (Invivogen) and Lipofectamine 2000 (Thermo Fisher Scientific) in Opti-MEM (Thermo Fisher Scientific) was prepared according to the manufacturer's instructions. For 96- and 12-well plates, 0.2 and 1.6 µg of poly(I:C) with 0.3 and 2.4 µL of lipofectamine were used, respectively. WT, ?F1L, and rF1L MVA viru

A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4-A damage-associated molecular pattern molecule

Abil, OZ;Liu, S;Yeh, YW;Wu, Y;Sen Chaudhuri, A;Li, NS;Deng, C;Xiang, Z;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • taur Molecular Products; 01-2081A4M; with His-tag) was administered dropwise to the external nares of the mice (10 ?l per nostril). Some mice were immunized with ESAT-6 (5 ?g) admixed to cholera toxin (CT; 1 ?g; List Biological Labs; 100B) as a control adjuvant. Ten days after the last intranasal immunization, various tissues and samples were collected and analyzed, including blood, bronchoalveolar lavage fluid (BALF), nasal lavage, lungs, and spleen. 2.3. Antigen recall responses

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Pertussis toxin List Biological Laboratories, Campbell, CA Cat# 181238A1

2-Bromo-1,4-Naphthalenedione promotes CD8+ T cell expansion and limits Th1/Th17 to mitigate experimental autoimmune encephalomyelitis

Yang, C;Ma, Y;Lu, Q;Qu, Y;Li, Y;Cheng, S;Xiao, C;Chen, J;Wang, C;Wang, F;Xiang, AP;Huang, W;Tang, X;Zheng, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • tide/CFA emulsion, with 50 µl injected subcutaneously at two separate sites on the back, resulting in four injections per mouse. Pertussis toxin (dissolved in sterile distilled water, 200 ng/mouse, List Biological Labs) was injected intraperitoneally on day 0 and day 2 following immunization. The mice were monitored daily and clinical appearance was scored on a scale of 0-5 as follows: 0, no ... tide/CFA emulsion, with 50 µl injected subcutaneously at two separate sites on the back, resulting in four injections per mouse. Pertussis toxin (dissolved in sterile distilled water, 200 ng/mouse, List Biological Labs) was injected intraperitoneally on day 0 and day 2 following immunization. The mice were monitored daily and clinical appearance was scored on a scale of 0-5 as follows: 0, no

ER-transiting bacterial toxins amplify STING innate immune responses and elicit ER stress

Schlenker, C;Richard, K;Skobelkina, S;Mathena, RP;Perkins, DJ;

Product: Pertussis Toxin Mutant

  • R9K;E129A mutant pertussis toxin was purchased from List Labs (cat no. 184). Purified cholera toxin was purchased from List Labs (cat no. 100B). Cholera toxin B

Melatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis

Álvarez-López, AI;Álvarez-Sánchez, N;Cruz-Chamorro, I;Santos-Sánchez, G;Ponce-España, E;Bejarano, I;Lardone, PJ;Carrillo-Vico, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • in CFA (Sigma) containing 50 ?g of heat-killed Mycobacterium tuberculosis (H37Ra, ATCC 25177) and two doses of intraperitoneal pertussis toxin (200 ng/day) (List Labs,

High fat low carbohydrate diet is linked to protection against CNS autoimmunity

Ni, D;Tan, J;Reyes, J;Senior, A;Andrews, C;Taitz, J;Potier, C;Wishart, C;Spiteri, A;Piccio, L;King, N;Barres, R;Raubenheimer, D;Simpson, S;Nanan, R;Macia, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • hondrex, Inc.) and 50 ?g desiccated Mycobacterium tuberculosis (strain H37RA). On the same day of immunization and 2 days after, mice received 300 ng/mouse pertussis toxin (List Biological Laboratories) via intravenous injection. After EAE induction, clinical symptoms of the mice were monitored following the

A network-based framework to discover treatment-response-predicting biomarkers for complex diseases

Shanthamallu, US;Kilpatrick, C;Jones, A;Rubin, J;Saleh, A;Barabási, AL;Akmaev, VR;Ghiassian, SD;

Product: Enterotoxin Type B from Staphylococcus aureus

  • urfaces faced the liquid-air interface. Culture plates were incubated in medium (37°C, 5% CO2) with either test compounds or vehicle. Tissues were treated with Staphylococcus enterotoxin B (List Biological Laboratories, Campbell, CA) to stimulate inflammatory cytokine secretion. Cell-culture supernatants (approximately 1 mL) were collected and flash frozen 18 hours after treatment. Two samples from each condition were stabiliz